Table 4.

Childhood Characteristics of Medication Subgroups

	None		One or less		1–5		Greater than 5
	n = 28		n = 19		n = 28		n = 22
Measure	Mean	SD	Mean	SD	Mean	SD	Mean	SD	F	p
Agea	9.44	1.56	9.51	1.41	8.81	1.16	8.53	1.31	3.38	0.02
SES	32.19	16.50	37.78	17.59	34.52	14.97	43.73	21.50	1.78	0.16
WISC-R/III - FSIQ	89.07	14.02	93.55	11.49	96.74	13.82	97.10	16.65	1.76	0.16
IOWA Conners
I/Ob	10.39	3.18	9.61	3.98	12.73	2.22	11.23	2.88	4.69	0.004
O/D	7.19	4.59	9.61	4.73	9.19	4.61	7.05	4.84	1.78	0.16
CBCL
Attention problems	71.00	10.84	72.00	10.68	75.16	9.43	70.25	9.22	1.10	0.36
Externalizing	67.07	11.38	71.67	10.32	73.00	9.64	67.05	13.14	1.79	0.16
Internalizingc	64.00	13.24	70.00	10.45	67.28	10.25	59.30	12.11	3.07	0.03
DISC									χ2	p
% CD	32.14		21.05		35.71		36.36		1.42	0.70
% ANX	35.71		47.37		21.43		27.27		3.91	0.27
% MOOD	10.71		10.53		10.71		9.09		0.05	0.99
% Receiving other pharmacologic treatment	10.71		26.32		25.00		36.36		6.08	0.11

^aPost hoc tests did not reveal any significant individual group differences.

^bIndividuals receiving medication for 1–5 years were significantly different than those receiving up to 1 year of medication.

^cIndividuals receiving treatment for up to 1 year were significantly different than those receiving medication greater than 5 years.